期刊文献+

利用活体成像技术对5型腺病毒在小鼠体内生物分布和表达的研究 被引量:2

The expression and distribution evaluation of AdS-Fluc in mice by in vivo bioluminescence imaging system
原文传递
导出
摘要 目的研究5型腺病毒(Ad5)不同途径感染小鼠后体内代谢和组织分布特点,为Ad5载体疫苗的应用和改造提供参考。方法构建携带萤火虫荧光素酶基因的Ad5-Fluc病毒并利用活体成像技术分析其感染BALB/c小鼠后的蛋白表达和组织分布特点,以及与裸鼠的感染特点进行比较。结果Ad5-Fluc肌肉途径感染BALB/c小鼠后出现肝脾转移表达的特点,且肌肉途径表达周期最长(〉60d),表达水平最高(P〈0.01)。病毒感染裸鼠后分布特点与BALB/c小鼠一致但表达周期明显延长。另外,用Ad35的纤突蛋白替代Ad5的纤突蛋白后的5型腺病毒载体(Ad5F35)在保持相似表达效率的同时消除了肝嗜性的特点。结论肌肉途径可能为5型腺病毒载体疫苗理想的免疫方式,同时Ad5F35病毒是一种理想的替代性腺病毒疫苗载体。 Objective To study the in vivo expression and biodistribution of AdS-Flac (Adenovi- rus carrying firefly luciferase genes) in mice. Methods The recombinant AdS-Fluc virus was constructed and infected to BALB/c or nude mice through three different routes. The protein expression level, tissue dis- tribution and the characteristics of infection were analyzed by in vivo bioluminescence imaging technology. Results Compared to other two routes, the BALB/c mice infected through muscular route had the longest expression cycle (over 60 days) and the highest expression level,while the virus was transferred into the liv- er and spleen after infection. The nude mice had a significantly extended expression cycle than BALB/c mice. Moreover, the characteristic of liver tropism was eliminated after AdS F35 infection in mice, while main- tained similar expression efficiency. Conclusion Due to the highest expression efficiency, the muscular route would be the optimal route for AdS vector based vaccination. In addition, Ad5F35 virus could become an ideal alternative vaccine vector for eliminating the liver tropism.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2012年第11期925-929,共5页 Chinese Journal of Microbiology and Immunology
关键词 腺病毒 体内分布 活体成像 BALB C小鼠 裸鼠 Adenovirus Distribution Bioluminescence imaging BALB/c mice Nude
  • 相关文献

参考文献5

二级参考文献33

  • 1Si, Zhong-Zhou,Li, Jie-Qun,Qi, Hai-Zhi,He, Zhi-Jun,Hu, Wei,Li, Yi-Ning.Recombinant adenovirus vector Ad-hIL-10 protects grafts from cold ischemia-reperfusion injury following orthotopic liver transplantation in rats[J].Hepatobiliary & Pancreatic Diseases International,2010,9(2):144-148. 被引量:11
  • 2丛喆,涂新明,李兆忠,许琰,蒋虹,佟巍,卢圣栋,魏强.SYBR Green Ⅰ实时荧光定量PCR法测定猴免疫缺陷病毒(SIV)前病毒DNA拷贝数方法的建立[J].中国比较医学杂志,2006,16(11):680-683. 被引量:5
  • 3卢曾军,曹轶梅,刘在新,谢庆阁.腺病毒载体在基因治疗和疫苗研究中的应用[J].中国病毒学,2006,21(6):622-625. 被引量:4
  • 4Kreuzer KA, Bohn A, Lupberger J, et al. Simultaneous absolute quantification of target and control templates by real-time fluorescence reverse transcription-PCR using 4-(4'-dimethylaminophenylazo) benzoic acid as a dark quencher dye. Clin Chem, 2001, 47 (3): 486-490. 被引量:1
  • 5Plog MS, Guyre CA, Roberts BL, et al. Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intraderreal delivery. Hum Gene Ther, 2006, 17 ( 7 ) : 705-716. 被引量:1
  • 6Wang Y, Yang Z, Liu S, et al. Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery. Br J Cancer, 2005, 92(8): 1414-1420. 被引量:1
  • 7ALEMANY R, CURIEL DT. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors [ J ]. Gene Thera- py, 2001, 8(17): 1347-1353. 被引量:1
  • 8PENG KW, PHAM L, YE H, et al. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors[J]. Gene Therapy, 2001, 8(19) : 1456 -1463. 被引量:1
  • 9KIM CY, PARK SH, JEONG M, et al. Preclinical studies for pharmacokinetics and biodistribution of Ad-stTR'AIL, an adenovi- rus delivering secretable trimeric TRAIL for gene therapy[ J]. Exp Mol Med, 2011, 43(10) : 580 -586. 被引量:1
  • 10HANKE T, MCMICHAEL AJ, SAMUEL RV, et al. Lack of toxici- ty and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara ( MVA)-based HIV vaccines for Kenya[ J ]. Vaccine, 2002, 21 ( 1 ) : 108 - 114. 被引量:1

共引文献14

同被引文献20

  • 1仲照东,邹萍,游泳,黄士昂.重组腺病毒AdEGFP/hVEGF165快速构建及在骨髓移植小鼠体内的分布和表达效率[J].中华实验和临床病毒学杂志,2004,18(1):35-38. 被引量:3
  • 2刘剑刚,董国菊,史大卓,王永炎.载脂蛋白E基因敲除小鼠不同周龄动脉粥样硬化的病理变化[J].中国动脉硬化杂志,2005,13(6):689-692. 被引量:23
  • 3Tilemann L, Ishikawa K, Weber T, et al. Gene therapy for heart failure[J]. Circ Res, 2012, 110(5) :777 -93. 被引量:1
  • 4Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in aornithine transcarbamylase deficient patient following adenoviral gene transfer[J]. Mol Genet Metab, 2003, 80 (1 -2) :148 -58. 被引量:1
  • 5Lopez- Gordo E, Denby L, Nicklin SA, et al. The importance of coagulation factors binding to adenovirus : historical perspectives and implications for gene delivery[ J]. Expert Opin Drug Deliv, 2014,11 (11) :1795 -813. 被引量:1
  • 6Noda A, Hirai Y, Kodama Y, et al. Easy detection of GFP - positive mutants following forward mutations at specific gene locus in cultured human cells[J]. Mutat Res, 2011,18;721(1) :101 -7. 被引量:1
  • 7Qin G, Luo L, Lv L, et al. Decision Iree analysis of traditional risk factors of carotid: atherosclerosis and 8. outpoint - based prevention strategy[J]. PLoSOne, 2014, 14; 9(11):e111769. 被引量:1
  • 8Dai Y, Qiao L, Chan KW, et al. Adenovirus - mediated down - regulation of X - linked inhibitor of apoptosis protein inhibits colon cancer[J]. Mol Cancer Ther, 2009, 8 (9) :2762 - 70. 被引量:1
  • 9Kubo S, Kataoka M, Tateno C, et al. In vivo stable transduction of humanized liver tissue in chimeric mice via high - capacity adenovirus - lentivirus hybrid vector[J]. Hum Gene Ther, 2010,21 ( 1 ) :40 -50. 被引量:1
  • 10Zhan Y, Yu B, Wang Z, et al. A fiber- modified adenovirus co - expressing HSV - TK and Coli. NTR enhances antitumor activities in breast cancer cells[ J]. Int J Clin Exp Pathol, 2014,7 (6) :2850-2860. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部